Ospraie Management, LLC 4

Accession 0000899243-21-011876

CIK 0001441693other

View on SEC.gov Company Profile

Filed

Mar 15, 8:00 PM ET

Accepted

Mar 16, 11:51 AM ET

Size

17.3 KB

Accession

0000899243-21-011876

Insider Transaction Report

Form 4

Period: 2021-03-15

MARRONE BIO INNOVATIONS INCMBII

Ospraie Holding I, L.P.

Director10% OwnerOther

Transactions

Exercise/Conversion
Common Stock, $0.00001 par value
2021-03-15$0.75/sh+4,264,299$3,198,224→ 67,282,675 total
Exercise/Conversion
Warrant
2021-03-15−4,264,299→ 0 total
Exercise: $0.75From: 2020-04-29Exp: 2021-03-15→ Common Stock (4,264,299 underlying)

Ospraie Management, Inc.

Director10% OwnerOther

Transactions

Exercise/Conversion
Warrant
2021-03-15−4,264,299→ 0 total
Exercise: $0.75From: 2020-04-29Exp: 2021-03-15→ Common Stock (4,264,299 underlying)
Exercise/Conversion
Common Stock, $0.00001 par value
2021-03-15$0.75/sh+4,264,299$3,198,224→ 67,282,675 total

Anderson Dwight

Director10% OwnerOther

Transactions

Exercise/Conversion
Warrant
2021-03-15−4,264,299→ 0 total
Exercise: $0.75From: 2020-04-29Exp: 2021-03-15→ Common Stock (4,264,299 underlying)
Exercise/Conversion
Common Stock, $0.00001 par value
2021-03-15$0.75/sh+4,264,299$3,198,224→ 67,282,675 total

Ospraie Ag Science LLC

Director10% OwnerOther

Transactions

Exercise/Conversion
Warrant
2021-03-15−4,264,299→ 0 total
Exercise: $0.75From: 2020-04-29Exp: 2021-03-15→ Common Stock (4,264,299 underlying)
Exercise/Conversion
Common Stock, $0.00001 par value
2021-03-15$0.75/sh+4,264,299$3,198,224→ 67,282,675 total

Ospraie Management, LLC

Director10% OwnerOther

Transactions

Exercise/Conversion
Common Stock, $0.00001 par value
2021-03-15$0.75/sh+4,264,299$3,198,224→ 67,282,675 total
Exercise/Conversion
Warrant
2021-03-15−4,264,299→ 0 total
Exercise: $0.75From: 2020-04-29Exp: 2021-03-15→ Common Stock (4,264,299 underlying)

Footnotes (3)

[F1]On March 15, 2021, Ospraie Ag Science LLC ("Ospraie LLC") exercised warrants to purchase Common Stock of Marrone Bio Innovations, Inc. (the "Issuer") and purchased the 4,264,299 shares of Issuer Common Stock underlying such warrants.
[F2]Ospraie Management, LLC ("Ospraie Management") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC. Ospraie Holding I, LP ("Ospraie Holding") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. ("Ospraie Inc.") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase Common Stock of the Issuer held by Ospraie LLC as the general partner of Ospraie Holding.
[F3](continued from footnote 2) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase Common Stock of the Issuer held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any.

Documents

2 files

Issuer

MARRONE BIO INNOVATIONS INC

CIK 0001441693

→

Entity typeother

IncorporatedDE

Related Parties

filerCIK 0001326533

Filing Metadata

Form type: 4
Filed: Mar 15, 8:00 PM ET
Accepted: Mar 16, 11:51 AM ET
Size: 17.3 KB

View on SEC.gov